Leadership Team

Doug is a consultant and relationship manager with over twenty-five years of domestic and international management experience. He works with client leaders to tackle the challenges within small and mid-sized organizations – often focusing on companies with unique modalities or first to market concepts. 

Has worked as CEO and entrepreneur in the IT service industry. Has supported for the pharmaceutical industry since the 1990s. Focuses on developing NDA as the undisputed global leader of strategic development advice, taking into account all critical commercial and regulatory considerations to successfully bring good medicines to patients in need.

Adam is a management consultant with over 15 years of consulting experience across a diverse group of clients. He has spent most of his career working with Life Science industry clients to devise and execute their business strategies.

Kim is a strategist with over a decade of experience across the healthcare industry. She has industry experience across pharmaceuticals, medical devices, diagnostics, payers, providers, government, non-profits, and has worked across some of the industry’s most innovative modalities (including gene therapy and digital therapies). She has functional experience in operational strategy, value realization, organizational design, data analytics, and program management.

Delphine is a senior pharma medical executive with broad European, US and global experience in the field of Medical Affairs, with a predominant focus on Oncology.

Laurie has over 25 years of global leadership experience in the pharmaceutical and biotechnology industries in drug development, regulatory strategy and regulatory approvals across all major therapeutic areas. She has led the development and commercialization of drugs for oncology, HIV/AIDS, cardiovascular, metabolics, immunology, infectious diseases, neuroscience, dermatology, inflammatory and immune-based diseases.

Laurie has led numerous multidisciplinary teams in over 50 US FDA and European EMA proceedings, including preparations.

Craig has over 20 years of diverse experience across Investment Banking and Corporate Finance for both public and private companies. He is passionate about helping companies achieve their strategic and financial growth objectives and increasing operational effectiveness.

Has worked as CEO and entrepreneur in the IT service industry. Has supported for the pharmaceutical industry since the 1990s. Focuses on developing NDA as the undisputed global leader of strategic development advice, taking into account all critical commercial and regulatory considerations to successfully bring good medicines to patients in need.

Laurie has over 25 years of global leadership experience in the pharmaceutical and biotechnology industries in drug development, regulatory strategy and regulatory approvals across all major therapeutic areas. She has led the development and commercialization of drugs for oncology, HIV/AIDS, cardiovascular, metabolics, immunology, infectious diseases, neuroscience, dermatology, inflammatory and immune-based diseases.

Laurie has led numerous multidisciplinary teams in over 50 US FDA and European EMA proceedings, including preparations.

Erik brings over 30 years of financial expertise and leadership to the company and is responsible for leading NDA's financial strategy, planning and analysis, and accounting functions.

Erik has a proven track record of driving growth, improving operational efficiency, and developing innovative financial solutions to help organizations succeed. 

Kim has 30 years of experience in global clinical and regulatory strategies for medicinal and aesthetic drugs and devices span all phases of development. Providing advice to clients on development and regulatory strategies and interactions with the FDA.  

Kim has extensive product development experience in multiple therapeutic areas including dermatology, respiratory, cardiovascular, hormone replacement, and autoimmune disorders.

Cathleen has over 25 years of experience in developing and managing business processes for consultancies across several industries. She was Executive Director of PharmApprove, now a specialty practice within NDA Group, for 15 years before moving into her current role of leading NDA’a global Operational Support team. 

Her extensive cross-functional business experience helps drive operational excellence by developing and delivering effective global processes to support NDA’s business units.

Erica provides leadership development and management support to advance our NDA culture bringing out the best in our people.
Experienced in the employee lifecycle, team and individual development, organizational changes, implementation strategies and employee engagement.
Erica has 10 years experience in industry.